President Yoon Suk Yeol has strongly reaffirmed the government's commitment to increase the medical school admission quota, aiming to tackle a persistent issue that has faced numerous setbacks in past administrations.In a statement from the Presidential Office in Yongsan on Monday, President Yoon ca
Merck Biopharma Korea's superovulation induction injection Pergoveris (follitropin alpha) will receive expanded reimbursement to treat patients with severe luteinizing hormone (LH) and follicle-stimulating hormone (FSH) deficiencies from Monday.Pergoveris is a superovulation induction injection cont
Leqvio (inclisiran), a cholesterol management drug that requires only two subcutaneous injections per year, is preparing to land in Korea.The Ministry of Food and Drug Safety (MFDS) is reportedly reviewing Novartis Korea's application to license Leqvio. Approval is expected as early as the first hal
JW Pharmaceutical said Monday that interim results from a long-term study of Hemlibra (emicizumab) in children with severe non-antibody hemophilia A confirmed that the drug improved joint health in patients.Hemlibra is a breakthrough medicine that mimics factor 8, a blood clotting factor deficient i
Lunit, a medical artificial intelligence (AI) company, said Monday it would present seven research findings using its AI biomarker platform, Lunit Scope, at the American Association for Cancer Research (AACR) 2024 in San Diego, Calif., from April 5-10.In a poster presentation, Lunit will demonstrate
MSD Korea said its new 15-valent pneumococcal protein conjugate vaccine, Vaxneuvance, will be available for free at hospitals and clinics nationwide starting Monday as part of the National Immunization Program (NIP) for children.Vaxneuvance is indicated for preventing invasive disease and pneumonia
A 33-month-old girl, rescued from an irrigation ditch while her parents were working on a farm in Boeun, North Chungcheong Province, died after a tertiary hospital refused to receive her, local media reports said. Nonetheless, an emergency medicine specialist noted that a tertiary hospital transfer
Daewoong Pharmaceutical's new Co-CEO Park Seong-soo, promoted from vice president, vowed to achieve 1 trillion won ($741.8 million) in operating profit under his leadership.Park was appointed as the company's new co-CEO following a board meeting held on Thursday.This strategic move transitions the c
Quratis, a Kosdaq-listed biotech company, said Friday that it has decided to establish a local corporation in the Philippines to tap into the country's tuberculosis vaccine market.Quratis has submitted an investigative new drug (IND) application for a phase 2b/3 clinical trial of “QTP101,” a TB vacc
The Korean government said its funding to hospitals for surgeries on severely ill children will drastically increase.The Ministry of Health and Welfare announced the "Pediatric Essential Medical Care Fee Plan" on Friday at a regular briefing of the Central Disaster and Safety Headquarters.Since last
Students from 40 medical schools nationwide have set about to file a class action lawsuit against the government to prevent the government from increasing the medical school enrollment quota.The Korean Association of Medical Colleges and Medical Graduate Schools (KAMC) has begun recruiting participa
After the plans to integrate Hanmi Group with OCI Holdings fell through, Hanmi officials withdrew from their nominations as internal directors at OCI Holdings.This development came ahead of OCI Holdings’ annual shareholders' general meeting on Friday, signaling a significant shift in the relationshi
On a bustling afternoon on Thursday, just minutes past 3:00 p.m., an outpour of cheers erupted from the crowd-packed SINTEX Hall in Suwon Science College in Suwon, Gyeonggi Province.The applause and shouts nearly blew the speakers in the press room as the two-month-long managerial dispute within the
The International Labor Organization (ILO) said it has intervened with the Korean government regarding Seoul’s order for trainee doctors to start work and called for it to resolve the issue through social dialogue.In response, the government said it would sincerely explain its position to the intern
The Ministry of Food and Drug Safety (MFDS) has warned consumers to be cautious about directly purchasing some foreign health supplements through online shopping malls at home and abroad.The ministry inspected 30 products for the spring season targeting the improvement of fine dust, respiratory, and
Starting April 1, Soliris, a complement C5 inhibitor, will be reimbursed for neuromyelitis optica spectrum disorder (NMOSD), expanding its health insurance coverage beyond paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).On Friday, AstraZeneca Korea announced t
Starting next month, health insurance benefits will be applied to treating metastatic breast and gastric cancers with Enhertu (trastuzumab deruxtecan) in Korea. On Thursday, the Ministry of Health and Welfare convened the Health Insurance Policy Deliberation Committee and approved the revised “Drug
D&D Pharmatech said Thursday that DD01, an injectable treatment for metabolic-associated steatohepatitis (MASH) being developed by the company, has received fast-track designation from the U.S. Food and Drug Administration. This is the second MASH treatment developed by a Korean company to receive t
CHA Biotech and Centenaire Biosciences have agreed to expand their collaboration on natural killer (NK) cell-antibody combination research. To this end, CHA Biotech transferred its NK cell therapeutic candidate to Centenaire Biosciences.The two companies will combine CHA Biotech's NK cells with Cent
In a pivotal shareholders' meeting of Hanmi Science on Thursday, the control tower within the Hanmi Group, the sons --Coree Group Chairman Lim Jong-yoon and Hanmi Fine Chemical CEO Lim Jong-hoon -- of the founding family secured a significant victory in the boardroom struggle against their mother an